Treatable Traits in Asthma
Involving patients and carers in decisions about their care and treatment is an integral part of providing truly patient-centred care.1 Person-centred care supports people to develop the knowledge, skills and confidence they need to more effectively manage and make informed decisions about their own health and care. It is coordinated and tailored to the needs of the individual.2
Traditionally, clinical guidelines have advocated a stepwise approach to pharmacotherapy of asthma and COPD, but there is an increasing realization that both require more personalized and precise management. To this end, a management strategy based on the so-called “Treatable Traits” has been proposed.3
A treatable trait is a characteristic amenable to therapy, with measurable benefits of treatment. This approach determines what pathology is actually present and treatable, rather than using umbrella labels.4
Dr Dhananjay Desai talks about the concept of treatable traits and how these can be identified using biomarkers in patients with asthma.
1. The King’s Fund. From vision to action. Making patient-centred care a reality. Available at: https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/Richmond-group-from-vision-to-action-april-2012-1.pdf
2. NHS England. Involving people in their own care. Available at:
3. Agusti A et al. Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. Respir Med. 2021 Oct;187:106572. doi: 10.1016/j.rmed.2021.106572.
4. Bush A, Pavord I. Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease Breathe Sep 2021, 17 (3) 210053; DOI: 10.1183/20734735.0053-2021.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Dr Dhananjay Desai
Dr Desai is a Consultant Respiratory Physician and was appointed at the University Hospitals Coventry and Warwickshire NHS Trust in 2014. He is currently the lead for Interstitial Lung Disease and provides care for a wide variety of respiratory conditions.
Dr Desai is involved with diagnostic procedures including pleural intervention and set up the Endobronchial Ultrasound (EBUS) service. He also undertook research into severe asthma with Professor Chris Brightling at Leicester and was awarded a PhD in 2016.